Josef Mališ
- Co-authors
- Ruth LadensteinEllen RuudPer KognerVassilios PapadakisGeneviève LaureysAna LacerdaWalentyna BalwierzPenelope Brock
- Topics
- Neuroblastoma Research and Treatments (11 papers)Renal and related cancers (7 papers)Cancer, Hypoxia, and Metabolism (5 papers)
- Cited by
- NeurologyCancer ResearchGenetics
In The Last Decade
Josef Mališ
22 papers receiving 297 citations
Peers
Comparison fields: 5 of 40
- Neurology 213
- Molecular Biology 148
- Cancer Research 93
- Oncology 66
- Epidemiology 40
Countries citing papers authored by Josef Mališ
This map shows the geographic impact of Josef Mališ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Mališ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Mališ more than expected).
Fields of papers citing papers by Josef Mališ
This network shows the impact of papers produced by Josef Mališ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Mališ. The network helps show where Josef Mališ may publish in the future.
Co-authorship network of co-authors of Josef Mališ
This figure shows the co-authorship network connecting the top 25 collaborators of Josef Mališ. A scholar is included among the top collaborators of Josef Mališ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Mališ. Josef Mališ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 5 | |
| 5 | Terapeutické možnosti u hemangiomů | 0 |
| 6 | 6 | |
| 7 | Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study | 1 |
| 8 | The prognostic value of semi-quantitative 123I MIBG scintigraphy at diagnosis in high risk neuroblastoma: validation of the SIOPEN score method | 9 |
| 9 | 6 | |
| 10 | 8 | |
| 11 | 95 | |
| 12 | [Late effect of treatment of nephroblastoma in patients treated in 1980-2001 in a single centre]. | 4 |
| 13 | [Treatment results in patients treated from 1980 to 2004 for Wilms' tumour in a single centre]. | 1 |
| 14 | 8 | |
| 15 | 6 | |
| 16 | [Clinical relevance of chromosomal aberrations in bone and soft tissue tumors in children and young adults]. | 0 |
| 17 | Embryonální rabdomyosarkom ledvinové pánvičky | 0 |
| 18 | 12 | |
| 19 | [The solitary kidney in patients after nephrectomy in Wilm's tumor]. | 3 |
| 20 | [Economic losses in influenza epidemics (author's transl)]. | 1 |
About Josef Mališ
Josef Mališ is a scholar working on Neurology, Ophthalmology and Cancer Research, having authored 27 papers that have together received 303 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (11 papers), Renal and related cancers (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Neurology (213 citations), Cancer Research (93 citations) and Genetics (33 citations). Josef Mališ has collaborated with scholars based in Czechia, Austria and Spain. Frequent co-authors include Ruth Ladenstein, Ellen Ruud, Per Kogner, Vassilios Papadakis, Geneviève Laureys, Ana Lacerda, Walentyna Balwierz, Penelope Brock, Ulrike Pötschger and Victoria Castel. Their work appears in journals such as Journal of Clinical Oncology, Genes Chromosomes and Cancer and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.